Wei‐Ting Chen

2.3k total citations
115 papers, 1.6k citations indexed

About

Wei‐Ting Chen is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Wei‐Ting Chen has authored 115 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hepatology, 57 papers in Epidemiology and 25 papers in Surgery. Recurrent topics in Wei‐Ting Chen's work include Liver Disease Diagnosis and Treatment (39 papers), Hepatocellular Carcinoma Treatment and Prognosis (34 papers) and Liver Disease and Transplantation (18 papers). Wei‐Ting Chen is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Hepatocellular Carcinoma Treatment and Prognosis (34 papers) and Liver Disease and Transplantation (18 papers). Wei‐Ting Chen collaborates with scholars based in Taiwan, United States and China. Wei‐Ting Chen's co-authors include Chun‐Yen Lin, Shi‐Ming Lin, I‐Shyan Sheen, Chen‐Chun Lin, Wen‐Juei Jeng, Ting‐Lan Ma, Shi‐Ming Lin, Wei Teng, Chen‐Chun Lin and Yu‐Pin Ho and has published in prestigious journals such as Psychological Bulletin, PLoS ONE and Hepatology.

In The Last Decade

Wei‐Ting Chen

110 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wei‐Ting Chen 726 707 279 142 133 115 1.6k
Ulf Hammar 590 0.8× 1.2k 1.7× 298 1.1× 120 0.8× 158 1.2× 67 2.3k
Rongbin Yu 530 0.7× 854 1.2× 174 0.6× 97 0.7× 95 0.7× 131 2.2k
Jiaye Liu 333 0.5× 364 0.5× 104 0.4× 125 0.9× 64 0.5× 51 1.6k
Gabriella Pár 371 0.5× 498 0.7× 320 1.1× 169 1.2× 129 1.0× 85 1.9k
Yasunori Sawayama 466 0.6× 496 0.7× 328 1.2× 24 0.2× 127 1.0× 52 1.2k
Mahmud Mahamid 253 0.3× 593 0.8× 397 1.4× 99 0.7× 121 0.9× 96 1.3k
Fernando Martínez 493 0.7× 551 0.8× 347 1.2× 28 0.2× 90 0.7× 72 2.2k
Raymundo Paraná 1.5k 2.0× 1.4k 1.9× 116 0.4× 88 0.6× 62 0.5× 154 2.1k
Douglas R. LaBrecque 1.7k 2.4× 1.7k 2.3× 751 2.7× 146 1.0× 202 1.5× 84 3.3k
Kaneez Fatima 195 0.3× 310 0.4× 113 0.4× 121 0.9× 53 0.4× 93 1.3k

Countries citing papers authored by Wei‐Ting Chen

Since Specialization
Citations

This map shows the geographic impact of Wei‐Ting Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ting Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ting Chen more than expected).

Fields of papers citing papers by Wei‐Ting Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Ting Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ting Chen. The network helps show where Wei‐Ting Chen may publish in the future.

Co-authorship network of co-authors of Wei‐Ting Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Ting Chen. A scholar is included among the top collaborators of Wei‐Ting Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Ting Chen. Wei‐Ting Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lee, Hsinyu, Chien‐Hua Huang, Wen‐Jone Chen, et al.. (2024). The compliance with TTM protocol may benefit outcomes in cardiac arrest survivors: A retrospective cohort study. The American Journal of Emergency Medicine. 84. 87–92. 2 indexed citations
3.
Chang, Ming‐Ling, Puo‐Hsien Le, Wei‐Ting Chen, et al.. (2024). Distinct characteristics of various autoimmune liver diseases: A 22‐year hospital‐based study in Taiwan. Journal of Gastroenterology and Hepatology. 39(12). 2835–2844. 2 indexed citations
5.
Lin, Shih‐Hua, Wei‐Ting Chen, Ming‐Hung Tsai, et al.. (2024). A novel prognostic model to predict mortality in patients with acute-on-chronic liver failure in intensive care unit. Internal and Emergency Medicine. 19(3). 721–730. 1 indexed citations
6.
Chang, Ting‐Tsung, Hung‐Tsung Wu, Chiung‐Yu Chen, et al.. (2023). Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma. Cancers. 15(3). 854–854. 3 indexed citations
7.
Li, Fudong, Puo‐Hsien Le, Kaihua Zhang, et al.. (2023). Artificial intelligence‐aided diagnostic imaging: A state‐of‐the‐art technique in precancerous screening. Journal of Gastroenterology and Hepatology. 39(3). 544–551. 2 indexed citations
8.
Algaissi, Abdullah, Jr‐Shiuan Lin, Wei‐Ting Chen, et al.. (2023). Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus. Vaccine. 41(21). 3337–3346. 8 indexed citations
9.
Chen, Wei‐Ting, Shi‐Ming Lin, Wei‐Chen Lee, et al.. (2022). GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial. Hepatology International. 16(1). 148–158. 11 indexed citations
10.
Hsieh, Cheng‐En, Jeng‐Hwei Tseng, Joseph Tung‐Chieh Chang, et al.. (2022). Proton Beam Therapy in Managing Unresectable Hepatocellular Carcinoma with Bile Duct Invasion. Cancers. 14(7). 1616–1616. 3 indexed citations
11.
Teng, Wei, Wen‐Juei Jeng, Wei‐Ting Chen, et al.. (2022). Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma. Cancer Medicine. 12(6). 7077–7089. 17 indexed citations
12.
Teng, Wei, Wen‐Juei Jeng, Wei‐Ting Chen, et al.. (2022). Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients. Cancer Medicine. 11(20). 3786–3795. 10 indexed citations
14.
Huang, Chien‐Hao, et al.. (2021). Comparing CLIF-C ACLF, CLIF-C ACLFlactate, and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure Patients by a Single-Center ICU Experience. Journal of Personalized Medicine. 11(2). 79–79. 8 indexed citations
15.
Cheng, Jur‐Shan, Jinghong Hu, Wei‐Ting Chen, et al.. (2021). Identification of the Representative Primary Biliary Cholangitis Cohort in Taiwan: A Comparison of Four Nationwide Cohorts. Journal of Clinical Medicine. 10(11). 2226–2226. 3 indexed citations
16.
Teng, Wei, Wei‐Ting Chen, Wen‐Juei Jeng, et al.. (2018). Timely eradication of HCV viremia by PegIFN/RBV is crucial in prevention of post RFA recurrence in CHC-HCC patients. Journal of the Formosan Medical Association. 118(8). 1239–1246. 3 indexed citations
17.
Wang, Chih‐Hung, Cheng‐Chung Fang, N. C. Chen, et al.. (2012). Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials.. PubMed. 172(13). 988–96. 125 indexed citations
18.
Chen, Wei‐Ting, Tung‐Liang Huang, Tai-Yi Chen, et al.. (2012). Does Transarterial Embolization Improve Survival for Recurrent Hepatocellular Carcinoma after Living Donor Liver Transplantation. 37(3). 101–104. 1 indexed citations
19.
Chen, Wei‐Ting, et al.. (2011). Pneumoperitoneum without Hollow Organ Perforation: A Case Report. 13(1). 48–52. 2 indexed citations
20.
Lin, Chen‐Chun, Chun‐Jung Lin, Wei‐Ting Chen, et al.. (2007). Treatment of Hepatocellular Carcinoma Using Internally Cooled Electrodes. Oncology. 72(Suppl. 1). 76–82. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026